brimonidine tartrate has been researched along with Leukoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kasuya, Y; Makino, S; Sano, I | 1 |
| Inoue, Y; Takai, Y; Tanito, M; Tsujinaka, A | 1 |
| Manabe, Y; Mochizuki, K; Sawada, A | 1 |
3 other study(ies) available for brimonidine tartrate and Leukoma
| Article | Year |
|---|---|
Interstitial Keratitis with Lipid Keratopathy Mimicking Corneal Opacity Induced by Brimonidine Tartrate Eye Drops.
Topics: Brimonidine Tartrate; Corneal Opacity; Humans; Keratitis; Lipids; Ophthalmic Solutions | 2020 |
A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Aged; Brimonidine Tartrate; Corneal Neovascularization; Corneal Opacity; Corneal Stroma; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Male; Slit Lamp Microscopy; Time Factors; Visual Acuity | 2019 |
Corneal sterile infiltration induced by topical use of ocular hypotensive agent.
Topics: Aged; Antihypertensive Agents; Bimatoprost; Blepharitis; Brimonidine Tartrate; Conjunctivitis; Corneal Neovascularization; Corneal Opacity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Low Tension Glaucoma; Male; Ophthalmic Solutions; Sulfonamides; Thiazines; Thiophenes | 2020 |